908 Devices Inc.

908 Devices Inc.

MASS · Nasdaq

908 Devices Inc. (MASS) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for 908 Devices Inc. in 2026. The next earnings report is expected on November 16, 2026.

Earnings calendar

Next earnings date

16 Nov 2026

In 87 days

EPS estimate

-0.10

Revenue estimate

18.5M

Past earnings

11 Aug 2026
EPS actual
-0.09 (+38.1%)
estimate -0.14
Revenue actual
4.9M (-68.1%)
estimate 15.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
—
estimate -0.14
Revenue actual
—
estimate 13.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 May 2026
EPS actual
-0.08 (+41.8%)
estimate -0.14
Revenue actual
13.4M (+1.7%)
estimate 13.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
03 Mar 2026
EPS actual
0.01 (+114.2%)
estimate -0.07
Revenue actual
17.4M (+9.7%)
estimate 15.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

908 Devices Inc. beat consensus estimates on EPS, with EPS of $-0.0879 versus an estimate of $-0.142, but missed on revenue as $4.9 million fell 68.1% short of estimates. In the prior quarter both EPS and revenue came in ahead of expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Sector
Healthcare
Industry
Medical devices
Country
United States
Exchange
Nasdaq
CEO
Kevin J. Knopp
Employees
246
IPO date
18 Dec 2020
ISIN
US65443P1021
Website
908devices.com

Frequently asked questions

When does 908 Devices Inc. (MASS) next report earnings?

908 Devices Inc. (MASS) is scheduled to report earnings on November 16, 2026.

What was 908 Devices Inc.'s most recent earnings date?

908 Devices Inc. (MASS) last reported earnings on August 11, 2026.

Where is 908 Devices Inc. stock listed?

908 Devices Inc. (MASS) is listed on Nasdaq.